In vitro evaluation of antibiotics for methicillin-resistant Staphylococcus aureus from North India

Indian Journal of Medical Research

Volumn 139, Issue FEB, 2014, Pages 319-322

  Mewara, Abhishek ^a   Gautam, Vikas ^a   Kaur, Harsimran ^a   Ray, Pallab ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; DAPTOMYCIN; LINEZOLID; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ABSCESS; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BURN; CELLULITIS; DISK DIFFUSION; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; SOFT TISSUE INFECTION; SURGICAL INFECTION; ULCER; DRUG EFFECTS; INDIA; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS;

DAPTOMYCIN; HUMANS; INDIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84897444524     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (21)

1. Pai V, Rao VI, Rao SP. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus [MRSA] isolates at a tertiary care hospital in Mangalore, South India. J Lab Physicians 2010; 2: 82-84.
2. Arora S, Devi P, Arora U, Devi B. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary care hospital in Northern India. J Lab Physicians 2010; 2: 78-81.
3. Chatterjee SS, Ray P, Aggarwal A, Das A, Sharma M. A community-based study on nasal carriage of Staphylococcus aureus. Indian J Med Res 2009; 130: 742-748.
4. Pathak A, Marothi Y, Iyer RV, Singh B, Sharma M, Eriksson B, et al. Nasal carriage and antimicrobial susceptibility of Staphylococcus aureus in healthy preschool children in ujjain, India. BMC Pediatr 2010; 10: 100.
5. Gould IM, Cauda R, Esposito S, Gudiol F, Mazzei T, Garau J. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits? Int J Antimicrob Agents 2011; 37: 202-209.
6. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52: 285-292.
7. Baird D. Staphylococcus: Cluster-forming Gram-positive cocci. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney practical medical microbiology. London, united Kingdom: Churchill Livingstone; 1996. p. 245-261.
8. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty-frst informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
9. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to effcacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42: 2398-2402.
10. Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, et al. Effcacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2010; 36: 182-186.
11. Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res 2011; 134: 704-708.
12. Palazzo IC, Araujo ML, Darini AL. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 2005; 43: 179-185.
13. Menezes GA, Harish BN, Sujatha S, Vinothini K, Parija SC. Emergence of vancomycin-intermediate Staphylococcus species in southern India. J Med Microbiol 2008; 57: 911-912.
14. Banerjee T, Anupurba S. Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center, In north India. J Clin Microbiol 2012; 50: 1730-1732.
15. Dhawan B, Gadepalli R, Rao C, Kapil A, Sreenivas V. Decreased susceptibility to vancomycin in meticillin-resistant Staphylococcus aureus: a 5 year study in an Indian tertiary hospital. J Med Microbiol 2010; 59: 375-376.
16. Levine DP. Clinical experience with daptomycin: bacteraemia and endocarditis. J Antimicrob Chemother 2008; 62 (Suppl 3): 35-39.
17. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-665.
18. Kaur R, Gautam V, Ray P, Singh G, Singhal L, Tiwari R. Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA). Indian J Med Res 2012; 136: 676-677.
19. Svetitsky S, Leibovici L, Paul M. Comparative effcacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 2009; 53: 4069-4079.
20. Kirby A, Graham R, Williams NJ, Wootton M, Broughton CM, Alanazi M, et al. Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, uK. J Antimicrob Chemother 2010; 65: 721-724.
21. Bressler AM, Zimmer SM, Gilmore JL, Somani J. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004; 4: 528-531.